SECdecoded Read filings, not jargon.

INCYTE CORPORATION FY 2025 10-K, explained in plain English

INCY · 10-K for the period ending December 31, 2025, filed February 10, 2026 · Read the original on SEC.gov →

Key financials — as reported

Total revenue$5.1B
Gross margin92.8%
Operating income$1.5B
Net income$1.3B
Diluted EPS$6.41
Cash & equivalents$3.1B
Total assets$7.0B
Long-term debt— not reported

Key takeaway

Incyte reported $5.14 billion in revenue and $1.29 billion in net income for fiscal 2025, driven by its JAKAFI and OPZELURA franchises.

🔒 4 more takeaways in the full analysis

Beneath the surface

The company reports a large deferred tax valuation allowance of $2.27 billion against gross deferred tax assets of $2.79 billion, suggesting substantial historical losses or uncertain future tax benefit realization not evident from headline net income.

🔒 3 more insights a headline reader would miss

This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for INCY.

Read the full analysis free Free account · 5 full analyses included · no card required